Unpacking Opioid Potency: Key Insights from Addiction Medicine
Episode Overview
Novel potent opioids' potency compared to fentanyl highlighted in a cohort study of over 500 patients Efficacy of smoking cessation interventions and the need for additional research on behavioral interventions discussed Survey findings revealing the impact of personal contact on reducing substance use stigma Association between diseases of despair and atherosclerotic cardiovascular diseases highlighted Retrospective study on alcohol consumption habits and the risk of atrial fibrillation detailed
The study found that NPOs may have a higher potency than fentanyl, shedding crucial light on opioid overdose treatment.
Curious about the latest in addiction medicine? This episode of 'This Week in Addiction Medicine' has got you covered. Hosted by Claire Rasmussen, it kicks off with a deep dive into a cohort study involving over 500 patients, comparing the potency of novel potent opioids (NPOs) to fentanyl. Spoiler alert: NPOs might just be more powerful than fentanyl, given the higher doses of naloxone needed to counteract their effects. Intrigued yet? That's just the beginning.
The episode also delves into a range of other compelling topics, from effective smoking cessation interventions to strategies for reducing substance use stigma. Ever wondered about the link between alcohol consumption and atrial fibrillation? Or perhaps you're interested in new therapeutic options for cocaine addiction and stress-related disorders? This episode covers all that and more. Plus, it sheds light on the increased risk of intellectual disability in children born to parents with substance use disorders.
Whether you're a healthcare professional, a student, or someone personally affected by addiction, this episode offers valuable insights and practical knowledge that could make a real difference.